Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
In this article:
Pfizer stock is now above its 50-day line on better-than-expected first-quarter sales. Is PFE stock a buy now?
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
Pfizer stock is now above its 50-day line on better-than-expected first-quarter sales. Is PFE stock a buy now?